Author Question: _________ is a drug developed specifically for the treatment of smoking and works by competing with ... (Read 96 times)

leilurhhh

  • Hero Member
  • *****
  • Posts: 560
_________ is a drug developed specifically for the treatment of smoking and works by competing with nicotine in binding to nicotine receptors in the brain.
 
  a. Varenicline
  b. Bupropion
  c. Fluoxetine
  d. Nicorette

Question 2

Research on the use of nicotine replacement therapies leads to the conclusion that _________.
 
  a. there are no demonstrable differences in effectiveness between different nicotine replacement therapies
  b. they are only slightly more effective than placebos
  c. there may be significant long-term consequences to their use
  d. pairing them with behavioral therapies does little to enhance treatment effectiveness



Laurenleakan

  • Sr. Member
  • ****
  • Posts: 309
Answer to Question 1

a

Answer to Question 2

a



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Stevens-Johnson syndrome and Toxic Epidermal Necrolysis syndrome are life-threatening reactions that can result in death. Complications include permanent blindness, dry-eye syndrome, lung damage, photophobia, asthma, chronic obstructive pulmonary disease, permanent loss of nail beds, scarring of mucous membranes, arthritis, and chronic fatigue syndrome. Many patients' pores scar shut, causing them to retain heat.

Did you know?

In the ancient and medieval periods, dysentery killed about ? of all babies before they reach 12 months of age. The disease was transferred through contaminated drinking water, because there was no way to adequately dispose of sewage, which contaminated the water.

Did you know?

More than 30% of American adults, and about 12% of children utilize health care approaches that were developed outside of conventional medicine.

Did you know?

Asthma is the most common chronic childhood disease in the world. Most children who develop asthma have symptoms before they are 5 years old.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library